DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

0.90 -0.02 (-2.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AVEO $0.90 -2.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.93
Previous Close $0.92
Daily Range $0.90 - $0.94
52-Week Range $0.85 - $2.20
Market Cap $47.1M
P/E Ratio -0.86
Dividend (Yield) $0.00 (0.0%)
Volume 146,685
Average Daily Volume 166,490
Current FY EPS -$1.07

Sector

Healthcare

Industry

Drugs

AVEO Pharmaceuticals, Inc. (AVEO) Description

AVEO Pharmaceuticals Inc. is a biopharmaceutical company. It is engaged in discovering developing and commercializing novel cancer therapeutics. Website: http://www.aveooncology.com/

News & Commentary

Mid-cap Biotechs are the Best Bet

Mid-cap biotechs have greatly outperformed their peers.

AVEO Gains on Tivozanib Agreement with Ophthotech - Analyst Blog

US Stock Futures Slightly Higher; Dollar Surges Against Yen

AVEO Enters into Research And Exclusive Option Agreement With Ophthotech For Tivozanib (VEGF inhibit

AVEO Enters into Research And Exclusive Option Agreement With Ophthotech For Tivozanib (VEGF inhibitor) For The Treatment Of Ocular Diseases

Will AVEO Pharmaceuticals (AVEO) Surprise this Earnings? - Analyst Blog

Leon Cooperman To Cash In On Atlas Energy Acquisition

AVEO-Biodesix Reveal Lung Cancer Study Exploratory Data - Analyst Blog

AVEO-Biodesix Reveal Lung Cancer Study Exploratory Data - Analyst Blog

BioMed Leases Space to Baxter for R&D Center in MA - Analyst Blog

AVEO Oncology Announces Lease Termination And Amendment To Debt Financing Facility

AVEO Oncology: A New Platform To Create Oncology Drugs

AVEO Pharmaceuticals (AVEO) Shares March Higher, Can It Continue? - Tale of the Tape

AVEO Pharmaceuticals (AVEO) Shares March Higher, Can It Continue? - Tale of the Tape

See More AVEO News...

AVEO's Top Competitors

AVEO $0.90 (-2.09%)
Current stock: AVEO
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB